ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

QLI Qilian International Holding Group Ltd

0.6842
-0.1048 (-13.28%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 12,501
Bid Price 0.6301
Ask Price 0.74
News -
Day High 0.82

Low
0.3551

52 Week Range

High
1.2974

Day Low 0.72
Share Name Share Symbol Market Stock Type
Qilian International Holding Group Ltd QLI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.1048 -13.28% 0.6842 18:53:15
Open Price Low Price High Price Close Price Previous Close
0.82 0.72 0.82 0.7486 0.789
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
90 12,501 US$ 0.7566748 US$ 9,459 - 0.3551 - 1.2974
Last Trade Type Quantity Price Currency
18:52:22 formt 200 US$ 0.6842 USD

Qilian International Holding Group Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
26.81M 35.75M - 46.47M -7.78M -0.22 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Qilian News

Date Time Source News Article
3/11/202405:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/15/202415:27Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private..
2/01/202415:15Edgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form..
1/12/202406:30PR Newswire (US)Qilian International Holding Group Receives 180-day..
12/07/202305:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202315:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/04/202315:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/25/202315:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/17/202309:30PR Newswire (US)Qilian International Holding Group Ltd Receives Nasdaq..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QLI Message Board. Create One! See More Posts on QLI Message Board See More Message Board Posts

Historical QLI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.74820.820050.64210.768957812,095-0.064-8.55%
1 Month0.74620.9640.55010.7242165300,962-0.062-8.31%
3 Months0.63360.9640.35510.6919111174,6810.05067.99%
6 Months0.59620.9640.35510.682352191,7100.08814.76%
1 Year1.181.29740.35510.687045846,752-0.4958-42.02%
3 Years4.354.990.35511.8428,318-3.67-84.27%
5 Years8.0122.000.35516.4174,770-7.33-91.46%

Qilian Description

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue.

Your Recent History

Delayed Upgrade Clock